The Changing Landscape of EEOC Enforcement and Disparate Impact
ESG Essentials: What You Need To Know Now - Episode 19 - Power Struggles: Federal vs. State Authority in Energy Law
Episode 366 -- DOJ Issues Data Security Program Requirements
Non-Competes Eased, Anti-DEI Rule Blocked, Contractor Rule in Limbo - Employment Law This Week® - #WorkforceWednesday®
CHPS Podcast Episode 3: Unlocking America's Mineral Potential
CHPS Podcast Episode 2: Bitcoin in the Halls of Power
Clocking in with PilieroMazza: Latest Developments on DEI Executive Order and Action Items before April 21 Deadline
Executive Actions Impact Federally Funded Research: What Institutions Should Do Now – Diagnosing Health Care Video Podcast
072: Prepare For Trump Executive Orders To Hit Your Law Firm
Compliance into the Weeds: The Role of Compliance Going Forward
#WorkforceWednesday®: Federal Contractors Alert - DEI Restrictions Reinstated by Appeals Court - Employment Law This Week®
Compliance into the Weeds: Global Anti-Corruption Leadership
State AG Pulse | DEI in the Federal and State Spotlight
FCPA Compliance Report: Navigating the Complexities of FTO Designations and Compliance in Mexico and Latin America
Daily Compliance News: March 21, 2025, The Fired Edition
The Regulatory Situation After the Trump Executive Orders Regulatory Freeze Pending Review
Work This Way: A Labor & Employment Law Podcast - Episode 40: Federal Contractors Under the 2nd Trump Administration with Joan Moore & Mim Munzel of The Arbor Consulting Group
A New Era at the Federal Election Commission?
Culture Crafters: Preventing and Fixing a Cultural Disconnect
#WorkforceWednesday®: Should Employers Shift Workforce Data Collection Under President Trump? - Employment Law This Week®
Requires the Secretary of Education to hold accreditors accountable who fail to meet the applicable recognition criteria or otherwise violate Federal law, including by requiring accreditation seeking institutions to engage in...more
The National Institutes of Health (NIH) announced on April 21, 2025, a significant change to the terms and conditions governing federal funding (the Notice) applicable to all NIH grants, cooperative agreements and other...more
The Trump Administration’s first two months have been marked by a flurry of actions impacting federal grant recipients, federal contractors, and academic and scientific researchers. These unprecedented measures, including...more
On March 14, 2025, the Fourth Circuit Court of Appeals issued a stay of the U.S. District Court’s preliminary injunction, which will allow the Trump administration to continue enforcing the Executive Orders (EOs) related to...more
The Trump administration continues to rollback policies on DEI and banking regulation while facing various lawsuits over its personnel, spending, and immigration actions....more
On March 7, 2025, the U.S. Department of Health and Human Services (HHS) announced that its Office for Civil Rights (OCR) had initiated four investigations into unnamed medical schools and hospitals over allegations that the...more
On March 7, 2025, the US Department of Health and Human Services (HHS) Office for Civil Rights (OCR) announced that it would begin investigating four medical schools and hospitals pursuant to President Donald Trump’s...more
The administration also turned its focus to copper imports, bird flu, and a proposed new path to American citizenship....more
If NIH succeeds in imposing an across-the-board indirect cost rate of 15%, rough estimates indicate the University of Michigan could lose $119 million a year. Emory University could be down $75 million. For the University of...more
A string of executive orders and an OMB memorandum from the Trump Administration left the status of almost all federal funding in a state of limbo. In particular, funding from the National Institutes of Health and for Health...more
In the first month of the second Trump presidency, the administration has focused on several executive orders and policy changes that may have significant implications for employer health and welfare plans. In a sweeping...more
Among the many issues raised by President Trump’s Executive Order (EO) 14173 (“Ending Illegal Discrimination and Restoring Merit-Based Opportunity”) targeting diversity, equity, and inclusion (DEI) programs is the prospect...more
For more than a decade, the Food and Drug Administration (FDA) has made diversity in clinical trials a focus, including by issuing guidance, convening public-private workshops, and completing data analyses in an effort to...more